CLOV
Clover Health·NASDAQ
--
--(--)
--
--(--)
CLOV fundamentals
During Q4 2025, Clover Health (CLOV) reported revenue of 487.71M, a YoY change of 44.74%. Net income was -49.32M, a YoY change of -123.25%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 165.50M -- | 172.08M -- | 169.07M -- | 166.23M -- | 200.32M +21.04% | 412.47M +139.70% | 427.16M +152.66% | 432.04M +159.90% | 874.38M +336.48% | 846.70M +105.27% | 856.82M +100.58% | -1.48B -442.88% | 321.99M -63.17% | 320.14M -62.19% | 306.03M -64.28% | 312.38M +121.09% | 346.92M +7.74% | 356.26M +11.28% | 330.99M +8.16% | 336.96M +7.87% | 462.33M +33.27% | 477.62M +34.07% | 496.65M +50.05% | 487.71M +44.74% | 1.92B -- |
Sales and Services Revenue | 165.50M -- | 172.08M -- | 169.07M -- | 159.04M -- | 200.32M +21.04% | 412.47M +139.70% | 427.16M +152.66% | 427.09M +168.54% | 874.38M +336.48% | 846.70M +105.27% | 856.82M +100.58% | -1.49B -449.58% | 317.09M -63.74% | 314.38M -62.87% | 301.23M -64.84% | 303.07M +120.30% | 341.72M +7.77% | 349.90M +11.30% | 322.58M +7.09% | 330.68M +9.11% | 456.91M +33.71% | 469.83M +34.27% | 479.13M +48.53% | 485.87M +46.93% | 1.89B -- |
Other Revenue | -- -- | -- -- | -- -- | 7.19M -- | -- -- | -- -- | -- -- | 4.94M -31.25% | -- -- | -- -- | -- -- | 11.68M +136.35% | 4.91M -- | 5.75M -- | 4.80M -- | 9.31M -20.27% | 5.20M +5.99% | 6.36M +10.51% | 8.41M +75.22% | 6.28M -32.55% | 5.42M +4.33% | 7.79M +22.55% | 17.52M +108.42% | 1.83M -70.79% | 32.58M -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 590.08M -- | -- -- | -- -- | -- -- | 1.55B +162.87% | -- -- | -- -- | -- -- | 993.07M -35.98% | 274.79M -- | 244.26M -- | 235.78M -- | 249.75M -74.85% | 265.16M -3.50% | 248.35M +1.67% | 249.77M +5.93% | 243.04M -2.69% | 353.44M +33.29% | 377.99M +52.20% | 423.47M +69.54% | 413.50M +70.13% | 1.57B -- |
Gross Profit | 165.50M -- | 172.08M -- | 169.07M -- | -423.85M -- | 200.32M +21.04% | 412.47M +139.70% | 427.16M +152.66% | -1.12B -164.04% | 874.38M +336.48% | 846.70M +105.27% | 856.82M +100.58% | -2.47B -121.10% | 47.20M -94.60% | 75.88M -91.04% | 70.24M -91.80% | 62.63M +102.53% | 81.76M +73.21% | 107.91M +42.22% | 81.21M +15.62% | 93.92M +49.96% | 108.89M +33.18% | 99.63M -7.68% | 73.18M -9.89% | 74.21M -20.99% | 355.90M -- |
Other Operating Income | -- -- | -- -- | -- -- | 17.13M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 93.52M -- | 1.81M -- | 5.14M -- | -- -- | 683.00K -99.27% | -- -- | -- -- | 538.00K -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- |
Operating Expenses | 192.13M -- | 148.91M -- | 190.69M -- | -339.09M -- | 319.41M +66.24% | 594.33M +299.12% | 576.42M +202.28% | -932.35M -174.96% | 961.86M +201.13% | 949.43M +59.75% | 930.91M +61.50% | -2.36B -152.97% | 128.71M -86.62% | 109.90M -88.43% | 103.86M -88.84% | 126.45M +105.36% | 104.46M -18.84% | 100.73M -8.34% | 90.53M -12.83% | 115.37M -8.76% | 110.16M +5.46% | 110.19M +9.39% | 97.55M +7.75% | 123.53M +7.07% | 441.43M -- |
Selling, General and Administrative Expenses | 50.09M -- | 40.85M -- | 46.61M -- | 55.09M -- | 104.80M +109.23% | 107.93M +164.23% | 119.33M +156.00% | 114.93M +108.61% | 127.61M +21.77% | 118.12M +9.44% | 118.59M -0.62% | 119.27M +3.78% | 126.90M -0.56% | 105.15M -10.98% | 102.15M -13.86% | 108.55M -8.99% | 104.11M -17.96% | 100.25M -4.65% | 90.53M -11.37% | 115.37M +6.28% | 110.16M +5.81% | 110.19M +9.91% | 97.55M +7.75% | 123.53M +7.07% | 441.43M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 120.83M -- | -- -- | -- -- | -- -- | 185.29M +53.35% | -- -- | -- -- | -- -- | 203.68M +9.93% | 57.64M -- | 41.71M -- | 41.03M -- | 42.70M -79.03% | 44.57M -22.68% | 44.42M +6.51% | 35.20M -14.21% | 52.29M +22.44% | 50.67M +13.70% | 48.48M +9.14% | 48.95M +39.07% | 66.16M +26.53% | 214.27M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 15.95M -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- |
Other Operating Expenses | 142.05M -- | 108.06M -- | 144.07M -- | -394.18M -- | 214.61M +51.09% | 486.40M +350.11% | 457.09M +217.26% | -1.05B -165.68% | 834.25M +288.72% | 831.31M +70.91% | 812.32M +77.72% | -2.48B -136.59% | 1.81M -99.78% | 4.75M -99.43% | 1.71M -99.79% | 1.95M +100.08% | 353.00K -80.46% | 473.00K -90.04% | -- -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -- | 0 -- | -- -- |
Operating Income | -26.63M -- | 23.17M -- | -21.62M -- | -67.63M -- | -119.09M -347.19% | -181.86M -884.90% | -149.25M -590.41% | -186.79M -176.20% | -87.48M +26.54% | -102.73M +43.51% | -74.10M +50.36% | -22.36M +88.03% | -79.70M +8.90% | -28.88M +71.88% | -33.62M +54.63% | -63.13M -182.35% | -22.70M +71.51% | 7.19M +124.88% | -8.79M +73.87% | -21.45M +66.03% | -1.27M +94.39% | -10.56M -246.92% | -24.38M -177.48% | -49.32M -129.95% | -85.53M -- |
Non-Operating Income (Loss) | -1.53M -- | -17.77M -- | 34.38M -- | -58.76M -- | 70.67M +4712.99% | -135.75M -664.05% | 114.73M +233.74% | -412.00K +99.30% | 11.99M -83.03% | -1.64M +98.80% | -1.39M -101.21% | 23.12M +5710.92% | 0 -100.00% | -7.00K +99.57% | 0 +100.00% | -4.81M -120.82% | -467.00K -- | -17.00K -142.86% | 0 -- | -33.00K +99.31% | 0 +100.00% | -19.00K -11.76% | 0 -- | -1.00K +96.97% | -20.00K -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 9.22M -- | 0 -- | 0 -- | 0 -- | -4.73M -151.27% | -467.00K -- | 0 -- | 0 -- | 0 +100.00% | 0 +100.00% | 0 -- | 0 -- | 0 -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | 13.42M -- | -- -- | -- -- | -- -- | 66.15M +392.78% | -- -- | -- -- | -- -- | 900.00K -98.64% | -- -- | 0 -- | 0 -- | -86.00K -109.56% | -- -- | -17.00K -- | 0 -- | -33.00K +61.63% | -- -- | -19.00K -11.76% | 0 -- | -1.00K +96.97% | -- -- |
Other Non-Operating Income (Loss) | 6.28M -- | -9.29M -- | 43.64M -- | -61.76M -- | 71.85M +1043.50% | -134.54M -1348.20% | 115.13M +163.79% | -66.16M -7.12% | 12.39M -82.75% | -1.25M +99.07% | -989.00K -100.86% | 13.14M +119.86% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 7.82M -- | 8.48M -- | 9.27M -- | 10.43M -- | 1.18M -84.96% | 1.21M -85.71% | 404.00K -95.64% | 403.00K -96.14% | 403.00K -65.70% | 390.00K -67.80% | 404.00K -- | 136.00K -66.25% | -- -- | 7.00K -98.21% | 0 -100.00% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Interest Expense | 7.82M -- | 8.48M -- | 9.27M -- | 10.43M -- | 1.18M -84.96% | 1.21M -85.71% | 404.00K -95.64% | 403.00K -96.14% | 403.00K -65.70% | 390.00K -67.80% | 404.00K -- | 136.00K -66.25% | -- -- | 7.00K -98.21% | 0 -100.00% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Pretax Income From Continuing Operations | -28.16M -- | 5.40M -- | 12.76M -- | -126.39M -- | -48.42M -71.92% | -317.61M -5978.42% | -34.53M -370.63% | -187.20M -48.11% | -75.49M -55.92% | -104.36M +67.14% | -75.49M -118.64% | 757.00K +100.40% | -79.70M -5.57% | -28.89M +72.32% | -33.62M +55.47% | -67.94M -9075.56% | -23.17M +70.93% | 7.17M +124.82% | -8.79M +73.87% | -21.48M +68.38% | -1.27M +94.50% | -10.58M -247.53% | -24.38M -177.48% | -49.32M -129.60% | -85.55M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -84.98M -- | 7.09M -- | 75.00K -- | -7.85M -- | -2.53M +97.03% | 4.00M -43.60% | 238.00K +217.33% | -370.00K +95.29% | -611.00K +75.82% | 0 -100.00% | 0 -100.00% | 0 +100.00% | 0 +100.00% | -- -- |
Net Income | -28.16M -- | 5.40M -- | 12.76M -- | -126.39M -- | -48.42M -71.92% | -317.61M -5978.42% | -34.53M -370.63% | -187.20M -48.11% | -75.49M -55.92% | -104.36M +67.14% | -75.49M -118.64% | -84.23M +55.01% | -72.61M +3.82% | -28.81M +72.39% | -41.47M +45.07% | -70.47M +16.33% | -19.17M +73.60% | 7.41M +125.71% | -9.15M +77.92% | -22.09M +68.65% | -1.27M +93.35% | -10.58M -242.79% | -24.38M -166.27% | -49.32M -123.25% | -85.55M -- |
Net Income Attributable to Owners of the Company | -28.16M -- | 5.40M -- | 12.76M -- | -126.39M -- | -48.42M -71.92% | -317.61M -5978.42% | -34.53M -370.63% | -187.20M -48.11% | -75.49M -55.92% | -104.36M +67.14% | -75.49M -118.64% | -84.23M +55.01% | -72.61M +3.82% | -28.81M +72.39% | -41.47M +45.07% | -70.47M +16.33% | -19.17M +73.60% | 7.41M +125.71% | -9.15M +77.92% | -22.09M +68.65% | -1.27M +93.35% | -10.58M -242.79% | -24.38M -166.27% | -49.32M -123.25% | -85.55M -- |
Net Income Attributable to Common Stockholders | -28.16M -- | 5.40M -- | 12.76M -- | -126.39M -- | -48.42M -71.92% | -317.61M -5978.42% | -34.53M -370.63% | -187.20M -48.11% | -75.49M -55.92% | -104.36M +67.14% | -75.49M -118.64% | -84.23M +55.01% | -72.61M +3.82% | -28.81M +72.39% | -41.47M +45.07% | -70.47M +16.33% | -19.17M +73.60% | 7.41M +125.71% | -9.15M +77.92% | -22.09M +68.65% | -1.27M +93.35% | -10.58M -242.79% | -24.38M -166.27% | -49.32M -123.25% | -85.55M -- |
Other Comprehensive Income | 1.72M -- | -394.00K -- | -611.00K -- | -754.00K -- | -493.00K -128.61% | 70.00K +117.77% | -197.00K +67.76% | -1.32M -75.60% | -5.32M -979.92% | -1.09M -1664.29% | -2.41M -1121.83% | 1.39M +204.68% | 2.34M +144.01% | 316.00K +128.86% | 1.64M +168.26% | 2.70M +94.95% | -190.00K -108.11% | 301.00K -4.75% | 3.11M +89.35% | -2.44M -190.16% | 1.51M +894.74% | 251.00K -16.61% | 294.00K -90.55% | 57.00K +102.34% | 2.11M -- |
Total Comprehensive Income | -26.44M -- | 5.01M -- | 12.15M -- | -127.14M -- | -48.91M -84.99% | -317.54M -6439.41% | -34.72M -385.86% | -188.53M -48.28% | -80.81M -65.23% | -105.46M +66.79% | -77.90M -124.33% | -82.84M +56.06% | -70.26M +13.06% | -28.50M +72.98% | -39.83M +48.87% | -67.77M +18.19% | -19.36M +72.45% | 7.71M +127.05% | -6.04M +84.82% | -24.53M +63.81% | 236.00K +101.22% | -10.33M -233.96% | -24.08M -298.46% | -49.26M -100.84% | -83.44M -- |
Total Comprehensive Income Attributable to Owners of the Company | -26.44M -- | 5.01M -- | 12.15M -- | -127.14M -- | -48.91M -84.99% | -317.54M -6439.41% | -34.72M -385.86% | -188.53M -48.28% | -80.81M -65.23% | -105.46M +66.79% | -77.90M -124.33% | -82.84M +56.06% | -70.26M +13.06% | -28.50M +72.98% | -39.83M +48.87% | -67.77M +18.19% | -19.36M +72.45% | 7.71M +127.05% | -6.04M +84.82% | -24.53M +63.81% | 236.00K +101.22% | -10.33M -233.96% | -24.08M -298.46% | -49.26M -100.84% | -83.44M -- |
Basic EPS | -0.32 -- | 0.02 -- | 0.06 -- | -1.22 -- | -0.13 +59.38% | -0.78 -4000.00% | -0.08 -233.33% | -0.4 +67.21% | -0.16 -23.08% | -0.22 +71.79% | -0.16 -100.00% | -0.18 +55.00% | -0.16 -- | -0.06 +72.73% | -0.09 +43.75% | -0.14 +22.22% | -0.04 +75.00% | 0.01 +116.67% | -0.02 +77.78% | -0.04 +71.43% | 0 +100.00% | -0.02 -300.00% | -0.05 -150.00% | -0.09 -125.00% | -0.16 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.17 -- | -0.06 -- | -0.07 -- | -- -- | -0.05 +70.59% | 0.01 +116.67% | -0.02 +71.43% | -- -- | 0 +100.00% | -0.02 -300.00% | -0.05 -150.00% | -- -- | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.01 -- | 0 -- | -0.02 -- | -- -- | 0.01 -- | 0 -- | 0 +100.00% | -- -- | 0 -100.00% | 0 -- | 0 -- | -- -- | -- -- |
Diluted EPS | -0.32 -- | 0.01 -- | 0.02 -- | -- -- | -0.13 +59.38% | -0.78 -7900.00% | -0.08 -500.00% | -- -- | -0.16 -23.08% | -0.22 +71.79% | -0.16 -100.00% | -- -- | -0.16 -- | -0.06 +72.73% | -0.09 +43.75% | -- -- | -0.04 +75.00% | 0.01 +116.67% | -0.02 +77.78% | -- -- | 0 +100.00% | -0.02 -300.00% | -0.05 -150.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.17 -- | -0.06 -- | -0.07 -- | -- -- | -0.05 +70.59% | 0.01 +116.67% | -0.02 +71.43% | -- -- | 0 +100.00% | -0.02 -300.00% | -0.05 -150.00% | -- -- | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.01 -- | 0 -- | -0.02 -- | -- -- | 0.01 -- | 0 -- | 0 +100.00% | -- -- | 0 -100.00% | 0 -- | 0 -- | -- -- | -- -- |
You can ask Aime
What is Clover Health's gross profit margin?What factors drove the changes in Clover Health's revenue and profit?What is the market's earnings forecast for Clover Health next quarter?Did Clover Health beat or miss consensus estimates last quarter?What is Clover Health's latest dividend and current dividend yield?What were the key takeaways from Clover Health's earnings call?What is the revenue and EPS growth rate for Clover Health year over year?What does Clover Health do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
